ACIP Recommends Four Newly Approved Influenza Vaccines

[SaneVax: During the last year, the FDA approved four new influenza vaccines. The Advisory Committee on Immunization Practices (ACIP) chose to postpone discussing new evidence indicating flu vaccine effectiveness may not last an entire flu season. They also postponed discussions on how medical professionals should choose which new flu vaccine to use. The only decision they made was to add all four new flu vaccines to those recommended for use during the next flu season. What is wrong with this picture?]

ACIP: Four Vaccines Added for the Next Flu Season

By Todd Neale, Senior Staff Writer, MedPage Today 

Four newly approved influenza vaccines were added to the guidance for the 2013-2014 season following a meeting of the Advisory Committee on Immunization Practices (ACIP).

At one of the committee’s regular meetings at CDC headquarters in Atlanta, ACIP members unanimously approved the addition of two quadrivalent vaccines, a cell culture-based vaccine, and a recombinant hemagglutinin vaccine produced using insect cell cultures. The additions were accompanied by new abbreviations that reflected the increasing variety of vaccine types beyond trivalent inactivated vaccine (TIV) and live-attenuated influenza vaccine (LAIV).

The new vaccines, all approved within the last year, are:

Read the entire article here.


Speak Your Mind